Ibutilide

59 interactions 4 explained in plain English
Also sold as: Corvert
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Moxifloxacin Ophthalmic Disopyramide Fostemsavir Deutetrabenazine Olodaterol Oral Inhalation Oxaliplatin Injection
59 Major
All (59) Major (59)

Major

Ibutilide Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Ibutilide Levofloxacin Levaquin An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Levofloxacin Injection Levaquin An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Ibutilide Mefloquine Lariam® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Metronidazole Flagyl An increased risk of QT interval prolongation Details Ibutilide Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Ibutilide Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Ibutilide Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Ibutilide Moxifloxacin Avelox Increased risk of QT interval prolongation Details Ibutilide Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Ibutilide Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Ibutilide Octreotide Bynfezia An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Octreotide Injection Bynfezia An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Ofloxacin Floxin® An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Ofloxacin Ophthalmic Ocuflox An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Ofloxacin Otic Floxin® Otic An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Ibutilide Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Ibutilide Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.